About Our Network
Connecting the people, researchers and communities in rare disease
25,000+
Membri affetti da malattie rare
300+
Centri medici in tutto il mondo
50+
Organizzazioni di pazienti
Come aiutiamo
Programs that utilize our patient network and real world data platform to power all stages of therapeutic development
Pre Clinical
Utilize our patient app and network to help with research, trial planning, and observational studies
Commercialization
Advanced patient reach and engagement for in market therapies through our app and patient network
Studi clinici
Proven, targeted patient recruitment program that’s successfully helped recruit over 40 global clinical trials
How it Works
Our AI tech platforms show insights on our programs through easy to use dashboards, providing metrics & transparency at all times
Machine learning–powered platform identifies eligible patients for clinical and observational trials, optimizing researcher–participant connection and accelerating study enrollment
AI-enabled platform delivering strategic insights from ongoing patient engagement and real-world data—driving smarter decisions across early to late-stage therapeutic development
Proven Results
Success across multiple therapeutic areas that have helped fuel programs and research studies throughout the world
60%
Average Network Engagement Rate
25%
Average Network Recontact Rate
75%
Average Rate for Randomization
-
Myasthenia Gravis (gMG)
Amyotrophic Lateral Sclerosis (ALS)
Tubular Sclerosis Complex (TSC)
-
Myositis (IIM)
Neuropatia motoria multifocale (MMN)
Systemic Lupus Erythematosus (SLE)
-
Bullous Pemphigoid (BP)
Pemphigus Vulgaris (PV)
-
NUT Carcinoma
Rare Liposarcoma
Acute Myeloid Leukemia (AML)
-
Sickle Cell Disease
Trombocitopenia immune (ITP)
Autoimmune Hemolytic Anemia (AIHA)
-
Sanfilippo Syndrome (MPS-III)
X-linked Myotubular Myopathy (XLMTM)
-
Focal Segmental-Glomerulosclerosis (FSGS)
Pulmonary Arterial Hypertension (PAH)
IgAN Kidney Disease
-
Prader Willi Syndrome (PWS)
Lysosomal Acid Lipase Deficiency (LALD)
Organic Acidemias (PA, MMA)
Ultime notizie Stampa
Leggi le ultime notizie su come stiamo facendo la differenza nelle malattie rare
Latest From Our Blog
Leggete i viaggi delle persone che vivono ogni giorno con una malattia rara e scoprite i ricercatori sulle malattie rare che lavorano per creare un futuro migliore.
UNA RESILIENZA ECCEZIONALE
CAMBIAVALUTE IN RARI
Entrare in Toccare
Contattateci ora per farci sapere come possiamo aiutare